News | July 29, 2024
Dr Reddys Laboratories posts Q1 FY25 consolidated PAT at Rs. 1,392 Cr
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
The drug will target specific genetic mutations prevalent in certain types of cancers
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Profit after tax (before exceptional items) up 23% to Rs 215 crores
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
Subscribe To Our Newsletter & Stay Updated
